Dublin, Dec. 19, 2018 (GLOBE NEWSWIRE) — The “Global Rapid Diagnostic Kits Market – Forecasts From 2018 to 2023” report has been added to ResearchAndMarkets.com’s offering.
The global Rapid Diagnostic Kits market is expected to reach US$28.885 billion by 2023 from US$18.725 billion in 2017 growing at a CAGR of 7.49%.
The market is expected to show significant growth during the forecast period owing to the high demand for the preventive management and rising awareness regarding early diagnosis of diseases across the globe. Technological advancements and continuous new product launches will also boost the growth of the market during the given forecast period.
Rising demand of the home based POC diagnostic kits will also fuel the growth of the Rapid Diagnostic Kits. However, Lack of awareness regarding newer rapid diagnostic tests coupled with the failure to eliminate the need for microscopy diagnosis might restrain the growth of the market during the given time frame.
Key Topics Covered
1. Introduction
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base and Forecast Years Timeline
2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. Key Findings of the Study
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. Global Rapid Diagnostic Kits Market Forecast by Technology
5.1. Lateral Flow Assays
5.2. Flow Through
5.3. Agglutination
5.4. Solid Phase
6. Global Rapid Diagnostic Kits Market Forecast by Application
6.1. Glucose Monitoring
6.2. Cardiometabolic Testing
6.3. Infectious Disease Testing
6.4. Drugs-of-Abuse Testing
6.5. Fertility and Pregnancy Testing
6.6. Others
7. Global Rapid Diagnostic Kits Market Forecast by End Users
7.1. Hospitals and Clinics
7.2. Diagnostic Centres
7.3. Home Care Settings
8. Global Rapid Diagnostic Kits Market Forecast by Geography
8.1. North America
8.2. South America
8.3. Europe
8.4. Middle East and Africa
8.5. Asia Pacific
9. Competitive intelligence
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. Company Profiles
10.1. Creative Diagnostics
10.2. Abbott
10.3. NanoRepro AG
10.4. Atlas Medical UK
10.5. Coris Bioconcept SPRL
10.6. F. Hoffmann-La Roche Ltd.
10.7. Meridian Bioscience Inc.
10.8. McKesson Medical-Surgical Inc.
10.9. ACON Laboratories Inc.
10.10. Alfa Scientific Designs Inc.
For more information about this report visit https://www.researchandmarkets.com/research/39twjj/the_28_billion?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics
